• Read more about Nowai Brapoh, PhD, RN, NPD-BC

Dr. Brapoh joined Cooper University Health Care in 2023. She provides strategic oversight for nursing quality, education, professional development, and wound care. 

• Read more about Marilyn Mapp, DNP, RN, NEA-BC

Dr. Mapp joined Cooper University Health Care in 2023. She provides operational oversight for the Women’s and Children’s Institute, including Obstetrics and Gynecology, Pediatrics, Child Life, Neonatal and Pediatric Critical Care, Cleft Palate Clinic, and the Safe Kids Outreach Program as well as Respiratory, Pulmonary Function Testing, and Interventional Pulmonary. 

• Read more about Karen Gruber, BSN, RN, CEN, NE-BC

Ms. Gruber joined Cooper in 1989 and has advanced from a staff nurse to her current position of Assistant Vice President, Nursing Operations. She provides operational oversight for Emergency Services, Urgent Care Centers, Inpatient Psychiatry, Cooper Transfer Center, Supplemental Staffing, and Logistics.

• Read more about Eileen F. Campbell, MSN, APN, FNP-BC

Ms. Campbell is the Chief Advanced Practice Provider. Her administrative responsibilities include oversight and standardization of recruitment/retention, professional development and engagement, quality and safety, education and research activities for Advanced Practice Providers (APPs) and Licensed Independent Practitioners (LIPs). This broad oversight includes Nurse Practitioners, Physician Assistants, CRNAs and Psychologists. Ms.

• Read more about Diane Floyd, BSN, MSN, CCRN, TCRN, NE-BC

Ms. Floyd started her nursing career in 1981 graduating with a diploma in nursing and immediately transitioned into critical care. Years at the bedside and desire to grow both in skill and knowledge resulted in further pursuit of career goals including a BSN and later a Master of Science in Nursing with an Emphasis in Nursing Education (MSN-Ed) degree.

• Read more about Kathy Devine, DrNP, RN, NEA-BC

Dr. Devine is responsible for professional nursing practice across the continuum of care to ensure safety, service, and quality outcomes for Cooper University Health Care's diverse patient population. In addition, she has administrative and operational leadership responsibility for Nursing and Patient Care Services. As SVP/CNE, Dr. Devine continues to advance nursing practice by engaging nurses in re-defining a professional practice model and shared governance structure that are grounded in theoretical tenets which align to organizational mission, vision, and values.

• Read more about MDA 2023-0228 dMMR Phoenix

Short Title: Phoenix

To learn if cemiplimab can help to control dMMR colon cancer.

Study Number:

2023-0228

Study Status:

Enrolling

Treatment Agent:

Cemiplimab

Resources and Links

National Clinical Trial Identified Number: NCT05961709

Disease:

• Colon

Study Phase:

II

researchcancer@cooperhealth.edu

Hide from Search:

Off

Physician Name:

• Jamin C. Morrison, MD, MBA

Department:

• Hematology and Medical Oncology,
• Colon Cancer Stages

• Read more about MDA 2016-0046 Exceptional Responders

Short Title: Exceptional Responders

This clinical trial studies eliminating surgery and how well radiation therapy after systemic therapy works in treating patients with HER2 positive or triple negative breast cancer when image-guided biopsy shows no residual cancer. Patients then receive standard breast radiotherapy.

Study Number:

2016-0046

Study Status:

Enrolling

Treatment Agent:

Radiation, Surgery

Resources and Links

National Clinical Trial Identified Number: NCT02945579

Disease:

• Breast Cancer,
• Estrogen Receptor Negative,
• HER2 Positive Breast Carcinoma,
• HER2/Neu Negative,
• Invasive Breast Carcinoma,
• Progesterone Receptor Negative,
• Triple-Negative Breast Carcinoma,
• Stage 1A, 1B, II, IIA, IIB

Study Phase:

Not applicable

researchcancer@cooperhealth.edu

Hide from Search:

Off

Physician Name:

• Catherine E. Loveland-Jones, MD, MS, FACS

• Read more about BR009

Short Title: BR009/OFSET

To determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).

Study Number:

BR009

Study Status:

Enrolling

Treatment Agent:

Ovarian Function Suppression, Aromatase Inhibitor, Adjuvant Chemotherapy, Ovarian Function Suppression

Resources and Links

National Clinical Trial Identified Number: NCT05879926

Disease:

• Breast Cancer

Study Phase:

III

ResearchCancer@CooperHealth.edu

Hide from Search:

Off

Physician Name:

• Danny Markabawi, MD

Department:

• Hematology and Medical Oncology

• Read more about LU008

Short Title: LU008

This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to standard treatment (image guided radiation therapy [IGRT] and chemotherapy followed by immunotherapy with durvalumab) versus standard treatment alone in treating patients with non-small cell lung cancer that cannot be treated by surgery (inoperable). SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. IGRT is a type of radiation that uses a computer to create picture of the tumor, to help guide the radiation beam during therapy, making it more accurate and causing less damage to healthy tissue.

Study Number:

LU008

Study Status:

Enrolling

Treatment Agent:

Cisplatin, Carboplatin, Paclitaxel, Pemetrexed, and Etoposide

Resources and Links

National Clinical Trial Identified Number: NCT05624996

Disease:

• Locally Advanced Lung Non-Small Cell Carcinoma,
• Stage IIB Lung Cancer AJCC v8,
• Stage III Lung Cancer AJCC v8

Study Phase:

III

ResearchCancer@CooperHealth.edu

Hide from Search:

Off

Physician Name:

• Joseph F. Lombardo, DO, PharmD

Department:

• Radiation Therapy,
• Lung Cancer